KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Tax Provisions (2017 - 2025)

Sarepta Therapeutics (SRPT) has 8 years of Tax Provisions data on record, last reported at $13.0 million in Q4 2024.

  • For Q4 2024, Tax Provisions rose 345.72% year-over-year to $13.0 million; the TTM value through Dec 2024 reached $25.8 million, up 62.38%, while the annual FY2024 figure was $25.8 million, 62.38% up from the prior year.
  • Tax Provisions reached $13.0 million in Q4 2024 per SRPT's latest filing, up from $371000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $13.0 million in Q4 2024 and bottomed at -$5.3 million in Q4 2023.
  • Average Tax Provisions over 5 years is $2.8 million, with a median of $855500.0 recorded in 2020.
  • Peak YoY movement for Tax Provisions: plummeted 1870.0% in 2021, then skyrocketed 8528.26% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $832000.0 in 2020, then plummeted by 88.94% to $92000.0 in 2021, then surged by 8528.26% to $7.9 million in 2022, then crashed by 166.57% to -$5.3 million in 2023, then surged by 345.72% to $13.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $13.0 million in Q4 2024, $371000.0 in Q3 2024, and $7.1 million in Q2 2024.